Clinical Journal of the American Society of Nephrology · 2008 · 63 citations · 31 references
MedicineGeneticsHematologyKidney TransplantationPediatric HematologyTransplant SurgeryHemolytic DisordersLiver DiseaseLiver TransplantationAnticoagulation In Kidney TransplantationComplement Factor H DeficiencyComplement-mediated Thrombotic MicroangiopathyMutationProphylactic AnticoagulationSubclinical Disease IdentificationSystemic AnticoagulationTherapeutic Plasma Exchange
BACKGROUND AND OBJECTIVES: A male infant with a family history of thrombotic microangiopathy developed atypical hemolytic uremic syndrome (aHUS). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Case report. RESULTS: Genetic analysis demonstrated a heterozygous mutation (S1191L) of CFH, the gene coding complement factor H (CFH). The child suffered many episodes of HUS, each treated with plasma exchange. In time, despite initiation of a prophylactic regimen of plasma exchange, his renal function declined significantly. At the age of 4 yr he received a (split liver) combined liver-kidney transplant (LKT) with preoperative plasma exchange and enoxaparin anticoagulation. Initial function of both grafts was excellent and is maintained for nearly 2 yr. CONCLUSIONS: This report adds to the small but growing number of individuals in whom LKT has provided a favorable outcome for aHUS associated with CFH mutation, expands the technique of using a split liver graft, and describes the unique histologic features of subclinical liver disease in HUS.
31
Jessica Caprioli, Federica Castelletti, Sara Bucchioni et al. · Human Molecular Genetics · 2003 · 308 citations